Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma

BACKGROUND: Apatinib, a vascular endothelial growth factor receptor 2 (VEGFR-2) inhibitor, has shown promising therapeutic effect for hepatocellular carcinoma (HCC). This prospective clinical study was implemented to evaluate the efficacy and safety of apatinib combined with transarterial chemoembol...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Transl Med
Hlavní autoři: Gu, Huiying, Li, Jing, You, Nan, Wu, Ke, Wang, Zheng, Wang, Liang, Zhu, Yinan, Liu, Qinqin, Peng, Xuehui, Zheng, Lu
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812192/
https://ncbi.nlm.nih.gov/pubmed/33490189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-7244
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky